Lisata Therapeutics (LSTA) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Lisata Therapeutics (LSTA) over the last 12 years, with Q3 2025 value amounting to 1.06%.
- Lisata Therapeutics' Return on Capital Employed fell 4000.0% to 1.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.06%, marking a year-over-year decrease of 4000.0%. This contributed to the annual value of 0.57% for FY2024, which is N/A changed from last year.
- Lisata Therapeutics' Return on Capital Employed amounted to 1.06% in Q3 2025, which was down 4000.0% from 0.92% recorded in Q2 2025.
- Lisata Therapeutics' 5-year Return on Capital Employed high stood at 0.4% for Q2 2023, and its period low was 1.06% during Q3 2025.
- In the last 3 years, Lisata Therapeutics' Return on Capital Employed had a median value of 0.59% in 2024 and averaged 0.65%.
- In the last 5 years, Lisata Therapeutics' Return on Capital Employed crashed by -500bps in 2024 and then tumbled by -4000bps in 2025.
- Over the past 3 years, Lisata Therapeutics' Return on Capital Employed (Quarter) stood at 0.52% in 2023, then tumbled by -40bps to 0.72% in 2024, then plummeted by -47bps to 1.06% in 2025.
- Its Return on Capital Employed stands at 1.06% for Q3 2025, versus 0.92% for Q2 2025 and 0.77% for Q1 2025.